Study of DF1001 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Bristol-Myers Squibb
Replimune Inc.
Myeloid Therapeutics
Bolt Biotherapeutics, Inc.
Compugen Ltd
Eli Lilly and Company
Fondazione per la Medicina Personalizzata
Fate Therapeutics
Fate Therapeutics
Jules Bordet Institute
Celgene